D. Fulton

发表

Prophylactic Anticonvulsants in Patients with Brain Tumour

G. Sutherland, L. Deangelis, P. Forsyth, 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Misonidazole combined with hyperfractionation in the management of malignant glioma.

K. Shin, R. Urtasun, P. Muller, 1984, International journal of radiation oncology, biology, physics.

A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium study.

M. Prados, M. Mehta, K. Fink, 2000, Neuro-oncology.

Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.

B. Murray, W. Roa, A. Murtha, 2006, Clinical and investigative medicine. Medecine clinique et experimentale.

Radiosensitivity testing of human primary brain tumor specimens.

R. Day, R. Urtasun, D. Fulton, 1992, International journal of radiation oncology, biology, physics.

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.

T. Hortobágyi, J. Olson, R. McLendon, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hyperfractionated radiation therapy for brain-stem glioma: a phase I-II trial.

Michael S. B. Edwards, M. Prados, J. Hannigan, 1989, Journal of neurosurgery.

Pharmacokinetic interaction of BCNU and misonidazole in humans.

R. Urtasun, R. Turner, D. Fulton, 1982, International journal of radiation oncology, biology, physics.

NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94).

K. Bélanger, L. Seymour, D. Macdonald, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical Correlations of Cerebrospinal Fluid Polyamine Levels

Charles B. Wilson, L. Marton, V. Levin, 1983 .

Phase II study of paclitaxel in patients with recurrent malignant glioma.

M. Berger, M. Prados, M. Gilbert, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Glutathione levels and chemosensitizing effects of buthionine sulfoximine in human malignant glioma cells

R. Day, B. Weir, R. Urtasun, 1991, Journal of Neuro-Oncology.

Brachial Plexopathy in Patients with Breast Cancer

D. Fulton, 1987 .

The Mer Minus Phenotype, Patient Response to Nitrosoureas, and Protooncogene Activation in Human Glioblastomas

J. Allalunis-Turner, R. Day, B. Weir, 1989 .

Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma

P. Forsyth, R. Urtasun, D. Fulton, 1996, Journal of Neuro-Oncology.

Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors

Charles B. Wilson, P. Gutin, V. Levin, 2004, Cancer Chemotherapy and Pharmacology.

Misonidazole and CCNU chemotherapy for recurrent primary brain tumor

R. Urtasun, D. Fulton, H. Tanasichuk, 2004, Journal of Neuro-Oncology.

Treatment of recurrent brain stem gliomas and other central nervous system tumors with 5-fluorouracil, CCNU, hydroxyurea, and 6-mercaptopurine.

M. Prados, V. Levin, M. Edwards, 1988, Neurosurgery.

The temozolomide RESCUE study: A phase II trial of continuous (28/28) dose-intense temozolomide (TMZ) after progression on conventional 5/28 day TMZ in patients with recurrent malignant glioma

W. Mason, K. Bélanger, D. Macdonald, 2008 .

An Open Label Trial of Sustained-release Cytarabine (DepoCyt™) for the Intrathecal Treatment of Solid Tumor Neoplastic Meningitis

M. Gilbert, W. Mason, E. Wong, 2004, Journal of Neuro-Oncology.

High Grade Glioma after Prophylactic Cranial Irradiation for Small Cell Lung Cancer

A. Fairchild, D. Yee, A. Joy, 2012 .

Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine

L. Recht, M. Gilbert, W. Mason, 2001, British Journal of Cancer.

Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma.

P. Gutin, V. Levin, M. Edwards, 1984, Journal of neurosurgery.

Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastoma

G. Barger, W. Wara, V. Levin, 1983, Cancer.

Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme.

W. Mason, K. Bélanger, D. Eisenstat, 2011, Current oncology.

High dose misonidazole with dexamethasone rescue: a possible approach to circumvent neurotoxicity.

A. Turner, R. Urtasun, D. Fulton, 1982, International journal of radiation oncology, biology, physics.

Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.

W. Mason, K. Bélanger, D. Eisenstat, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival improvement in anaplastic astrocytoma, combining external radiation with halogenated pyrimidines: final report of RTOG 86-12, Phase I-II study.

T. Kinsella, N. Farnan, J. Delrowe, 1996, International journal of radiation oncology, biology, physics.

Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.

M. Berger, M. Prados, M. Gilbert, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

T. Cascino, J. Buckner, D. Macdonald, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Canadian recommendations for the treatment of glioblastoma multiforme

W. Mason, D. Eisenstat, D. Macdonald, 2007, Current oncology.

Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferons.

J. Allalunis-Turner, J. Miyakoshi, K. Petruk, 1990, Cancer research.

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

E. Bruera, B. Fisher, J. Cairncross, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy of pediatric brain-stem tumors.

W. Wara, V. Levin, M. Edwards, 1981, Journal of neurosurgery.

Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine.

W. Wara, R. Davis, V. Levin, 1988, Journal of neurosurgery.

A Phase I Study of Tomotherapy in Patients With Primary Benign and Low-grade Brain Tumors: Late Toxicity and Quality of Life

B. Fisher, Sunita Ghosh, G. Bauman, 2016, American journal of clinical oncology.

Cerebrospinal fluid polyamines in patients with Glioblastoma multiforme and anaplastic astrocytoma.

L. Marton, V. Levin, C. Wilson, 1980, Cancer research.

Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme

M. Mackenzie, Sunita Ghosh, W. Roa, 2010, Radiation oncology.

Effect of radiation on cytokine and cytokine receptor messenger-RNA profiles in p53 wild and mutated human glioblastoma cell lines.

H. T. Chen, W. Roa, R. Coupland, 2001, Clinical and investigative medicine. Medecine clinique et experimentale.

Optic nerve sheath fenestration for a reversible optic neuropathy in radiation oncology.

W. Roa, N. Jha, D. Fulton, 2000, American journal of clinical oncology.

X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.

W. Roa, J. Th’ng, Andrew R Shaw, 2003, Clinical and investigative medicine. Medecine clinique et experimentale.

Changes in serial magnetic resonance spectroscopy predict outcome in high-grade glioma during and after postoperative radiotherapy.

Sunita Ghosh, W. Roa, A. Murtha, 2011, Anticancer research.

Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: a comparison of short versus long intravenous dose schedules (RTOG 86-12).

T. Kinsella, T. Wasserman, J. Delrowe, 1993, International journal of radiation oncology, biology, physics.

Polyamine levels in CSF from patients with pituitary tumors or nonneoplastic pituitary disease.

L. Marton, C. Wilson, D. Fulton, 1982, Archives of neurology.

Misonidazole with dexamethasone rescue: an escalating dose toxicity study.

R. Urtasun, D. Fulton, J. Raleigh, 1984, International journal of radiation oncology, biology, physics.

Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma

M. Feldstein, R. Urtasun, J. Hanson, 1992, Journal of Neuro-Oncology.

Which glioblastoma multiforme patient will become a long‐term survivor? A population‐based study

J. Cairncross, P. Forsyth, J G Cairncross, 1999, Annals of neurology.

Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996.

L. Deangelis, L. Difrancesco, P. Forsyth, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

BAILLIERE'S CLINICAL NEUROLOGY: INTERNATIONAL PRACTICE AND RESEARCH-CEREBRAL GLIOMAS. 1996. Edited by W.K.A. Yung. Published by Harcourt Brace. 445 pages. $C39.00 approx.

D. Fulton, 1997, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996.

L. Deangelis, L. Difrancesco, P. Forsyth, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.